#biotech

🏢Release 📈 Stocks

QuantumPharm Launches Kodexia siRNA Platform to Accelerate Drug Discovery

October 6, 2026 (35 days ago)

QuantumPharm (2228.HK) introduces Kodexia, an integrated siRNA platform combining sequence design and experimental validation to shorten drug discovery timelines.

2228.HK

🌍 ASIA Read More →

🏢Release 📈 Stocks

Repligen Completes Acquisition of BioLife Solutions to Expand Cell Therapy

October 6, 2026 (35 days ago)

Repligen Corporation completes its acquisition of BioLife Solutions, adding key biopreservation media assets and expanding its global footprint in the cell therapy…

BLFS RGEN

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Oak Hill Bio Appoints Joerg Hipp as Chief Translational Science Officer

October 6, 2026 (35 days ago)

Oak Hill Bio strengthens its leadership team with the appointment of Dr. Joerg Hipp as Chief Translational Science Officer to advance its…

Oak Hill Bio

🌍 US Read More →

🏢Release 📈 Stocks

Veeva Systems DQS Processes 1 Million Clinical Subjects Across 1,000 Studies

October 6, 2026 (35 days ago)

Veeva Systems reports its DQS platform has surpassed 1 million subjects processed, highlighting significant operational gains in clinical data management and cost…

VEEV

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

AnnJi Pharmaceutical Advances AJ201 to Phase 3 Trial for SBMA Treatment

October 6, 2026 (35 days ago)

AnnJi Pharmaceutical initiates Phase 3 testing for AJ201, the only clinical-stage oral therapy currently in development for spinal and bulbar muscular atrophy…

AnnJi Pharmaceutical

🌍 ASIA Read More →

🏢Release 📈 Stocks

Mozart Therapeutics Reports Positive Phase 1 Data for MTX-101 in Type 1 Diabetes

October 5, 2026 (35 days ago)

Mozart Therapeutics advances its clinical pipeline with positive Phase 1 and preclinical data for MTX-101, showing therapeutic potential in treating Stage 3…

Mozart Therapeutics

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

BioMarin Appoints Cara Bauer as Chief People Officer Effective Oct. 5

October 5, 2026 (35 days ago)

BioMarin Pharmaceutical Inc. (BMRN) appoints industry veteran Cara Bauer as Chief People Officer to lead human resources strategy effective immediately.

BMRN

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

AbbVie and Genmab Report Positive Phase 3 Results for Epcoritamab in DLBCL

October 5, 2026 (35 days ago)

AbbVie and Genmab shares gain as the EPCORE DLBCL-2 trial demonstrates superior progression-free survival for frontline lymphoma patients using their bispecific antibody…

ABBV GMAB

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

Lanterne Dx Completes Merger with Flagship Biosciences to Scale CRO Services

October 5, 2026 (36 days ago)

Lanterne Dx merges with Flagship Biosciences, combining histopathology expertise with computational biology to expand its clinical research service portfolio under a unified…

Lanterne Dx Flagship Biosciences

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

Provectus Biopharmaceuticals Reports 95.5% Response Rate in Oral Cancer Trial

October 5, 2026 (36 days ago)

Provectus Biopharmaceuticals shares rally as Phase 2 trial data for PRV111 shows a 95.5% pathologic complete response rate in early-stage oral cancer…

PVCT

🌍 AMERICAS Read More →

🏢Release 📈 Stocks

EpiSign and Geneyx Partner to Integrate DNA Methylation Analysis

October 5, 2026 (36 days ago)

EpiSign and Geneyx join forces to merge DNA methylation analysis with multi-omics platforms, aiming to improve diagnostic precision and expand market reach…

EpiSign Inc. Geneyx Genomex Ltd.

🌍 GLOBAL Read More →

🏢Release 📈 Stocks

FDA Approves OMLYCLO as First Interchangeable Biosimilar to XOLAIR

October 5, 2026 (36 days ago)

OMLYCLO secures FDA approval as the first interchangeable biosimilar to XOLAIR, set to be available in multiple dosage strengths to challenge existing…

GSK MRK

🌍 AMERICAS Read More →